Lv, L., Yang, J., Dou, L. (2025). Venetoclax-azacitidine-chidamide plus CAG (CACAG-VEN) versus “3+7” induction chemotherapy in  Intermediate-adverse Acute Myeloid Leukemia: Efficacy and safety. Blood. https://doi.org/10.1182/blood-2025-5236